Improved success rate of cardiac resynchronization therapy implant by employing an active fixation coronary sinus lead
Open Access
- 21 March 2010
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 12 (6), 825-829
- https://doi.org/10.1093/europace/euq078
Abstract
Cardiac resynchronization therapy (CRT) is the standard treatment for heart failure with severe reduced left ventricular (LV) function and wide QRS complex. Coronary sinus (CS) lead implantation is challenging and accompanied by substantial dislocation rates. We evaluated the usage of an active fixation LV lead (Attain Starfix™, Medtronic, MN, USA) with deployable lobes in challenging lead positions. Between September 2006 and August 2009, 678 CRT devices were implanted. In 82 patients (12%) (59 male, 70 ± 10 years, 39 ICM, 41 DCM, 2 valvular CM, LVEF 28 ± 9%, NYHA 3.0 ± 0.4, QRS 169 ± 29 ms), the Attain Starfix active fixation lead was used. The main reason was intra-operative dislodgement of one ( n = 47) or two ( n = 5) passive fixation leads during implantation or revision procedure ( n = 30). Active fixation lead implantation was overall successful with 90% ( n = 74). Anatomical peculiarity was mostly an optimal lead position in otherwise unstable proximal parts of the target vein or a circumscripted areal of optimal threshold without phrenic nerve stimulation. At median follow-up of 99 days the threshold remained stable (1.2 ± 0.8 vs. 1.0 ± 0.5 V at 0.5 ms). Revisions due to instability in ectatic vein ( n = 1) after 12 months and extractions ( n = 2) because of device perforation/infection after 6/15 months were performed without complication. The Attain Starfix active fixation lead proved to be an important option in anatomically challenging, otherwise unstable positions often located in the proximal part of the target vein. Lead revisions or extractions as late as 15 months after implantation were feasible.Keywords
This publication has 17 references indexed in Scilit:
- In the field of cardiac resynchronization therapy is left ventricular pacing via the coronary sinus a mature technique.EP Europace, 2009
- ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic SurgeonsJournal of the American College of Cardiology, 2008
- Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm AssociationEuropean Heart Journal, 2007
- First experience with a new active fixation coronary sinus leadEP Europace, 2007
- Implantation of Active Fixation Leads in Coronary Veins for Left Ventricular Stimulation: Report of Five CasesPacing and Clinical Electrophysiology, 2007
- Effect of Percutaneous Interventions within the Coronary Sinus on the Success Rate of the Implantations of Resynchronization PacemakersPacing and Clinical Electrophysiology, 2006
- Safety of Transvenous Cardiac Resynchronization System Implantation in Patients With Chronic Heart Failure: Combined Results of Over 2,000 Patients From a Multicenter Study ProgramJournal of the American College of Cardiology, 2005
- Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart FailureThe New England Journal of Medicine, 2004
- Cardiac Resynchronization in Chronic Heart FailureThe New England Journal of Medicine, 2002
- Is the prognosis of heart failure improving?Journal of the American College of Cardiology, 2000